P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

December 2006

Features

Formulary Substitution of Proton Pump Inhibitors Based on Acquisition Price: Changes in Usage and Costs of Acid-Suppressant Therapies

The authors discuss changes that occurred after three PPIs were removed from a hospital formulary and one less expensive, preferred PPI was added.
Robert MacLaren, PharmD, Tyree H. Kiser, PharmD, Rose Jung, PharmD, and Douglas N. Fish, PharmD

Meeting Highlights

53rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry

The authors review approaches for attention-deficit/hyperactivity disorder, mood disorders, bipolar disorder, mania, acute agitation, tic disorder or Tourette syndrome, binge-eating disorders, and the risk of suicidal behavior.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Meeting Highlights

Chemotherapy Foundation Symposium XXIV: Innovative Cancer Therapy for Tomorrow

Standard and novel agents for various hematological malignancies include therapies for Hodgkin’s lymphoma, chronic lymphocytic leukemia, acute and chronic myelogenous leukemia, myelodysplastic syndromes, and multiple myeloma.
Marvin M. Goldenberg, PhD, RPh, MS

Alternative Medicine

Ginseng Extract: Immune System Builder

COLD-fX, which differs from generic ginseng, affects both innate and acquired immune responses. The results of pivotal clinical trials are discussed.
Walter Alexander

Continuing Education Credit

Manifestation of Adult Attention-Deficit/Hyperactivity Disorder and Available Treatment Options

For many years, attention-deficit/hyperactivity disorder was thought to affect only children and adolescents. The authors describe ADHD in adults and review the efficacy of the drugs prescribed for this population.
Joshua J. Gagne, PharmD, Madhusree Singh, MD, and Amy R. Talati, PharmD

Season's Greetings: Thanks to Our Readers and Reviewers

Departments

Editorial

Are We There Yet?

Karl Matuszewski, MS, PharmD, discusses the need for hospitals to evaluate the cost-effectiveness of new technology.
Karl Matuszewski, MS, PharmD

Prescription: Washington

Congress Has Full Plate of Drug Legislation: Some Dishes More Palatable Than Others

Stephen Barlas discusses some upcoming bills for the new Congress on drug importation, Medicare Part D drug prices, and the FDA’s role in approving generic biotechnology drug approvals and curbing the marketing of new drugs.
Stephen Barlas

Medication Errors

Ephedrine and Epinephrine: An Easy Opportunity for Confusion

Matthew Grissinger, RPh, FASCP, reports on the confusion between epinephrine and ephedrine and offers strategies to reduce errors.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

The Clinical Use of Tipranavir in HIV Infection

The authors review the clinical use of tipranavir (Aptivus) for HIV infection.
Angela Thornton, PharmD, Helen Y. Choy, PharmD, BCPS, Evans Branch III, PharmD, and Marlon Honeywell, PharmD